{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:53:31Z","timestamp":1782604411723,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005270","name":"fujian provincial department of science and technology","doi-asserted-by":"publisher","award":["2018Y9033"],"award-info":[{"award-number":["2018Y9033"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00405-021-07065-0","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T09:02:56Z","timestamp":1630746176000},"page":"2625-2630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A retrospective study of 44 patients with head and neck Castleman\u2019s disease"],"prefix":"10.1007","volume":"279","author":[{"given":"Taiqin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3666-993X","authenticated-orcid":false,"given":"Jianzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,4]]},"reference":[{"issue":"23","key":"7065_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/nejm195406102502308","volume":"250","author":"B Castleman","year":"1954","unstructured":"Castleman B, Towne VW (1954) Case records of the Massachusetts General Hospital: Case No. 40231. N Engl J Med 250(23):1001\u20131005. https:\/\/doi.org\/10.1056\/nejm195406102502308","journal-title":"N Engl J Med"},{"issue":"3","key":"7065_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00784-017-2232-x","volume":"22","author":"X He","year":"2018","unstructured":"He X, Wang Q, Wu Y et al (2018) Comprehensive analysis of 225 Castleman\u2019s diseases in the oral maxillofacial and neck region: a rare disease revisited. Clin Oral Investig 22(3):1285\u20131295. https:\/\/doi.org\/10.1007\/s00784-017-2232-x","journal-title":"Clin Oral Investig"},{"issue":"3","key":"7065_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-#","volume":"29","author":"AR Keller","year":"1972","unstructured":"Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29(3):670\u2013683. https:\/\/doi.org\/10.1002\/1097-0142(197203)29:3%3c670::aid-cncr2820290321%3e3.0.co;2-#","journal-title":"Cancer"},{"key":"7065_CR4","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7625","author":"JP Jiang","year":"2017","unstructured":"Jiang JP, Shen XF, Du JF, Guan WX (2017) A retrospective study of 34 patients with unicentric and multicentric Castleman\u2019s disease: experience from a single institution. Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2017.7625","journal-title":"Oncol Lett"},{"issue":"11","key":"7065_CR5","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.21037\/jtd.2019.10.73","volume":"11","author":"M Wojtys","year":"2019","unstructured":"Wojtys M, Piekarska A, Kunc M et al (2019) Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review. J Thorac Dis 11(11):4859\u20134874. https:\/\/doi.org\/10.21037\/jtd.2019.10.73","journal-title":"J Thorac Dis"},{"issue":"2","key":"7065_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00296-020-04684-4","volume":"41","author":"FG Demirkan","year":"2021","unstructured":"Demirkan FG, Dogan S, Kalyoncu Ucar A, Sonmez HE, Aktay AN (2021) Systemic lupus erythematosus complicated with Castleman disease: a case-based review. Rheumatol Int 41(2):475\u2013479. https:\/\/doi.org\/10.1007\/s00296-020-04684-4","journal-title":"Rheumatol Int"},{"issue":"7","key":"7065_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.crad.2003.10.025","volume":"59","author":"JC Hillier","year":"2004","unstructured":"Hillier JC, Shaw P, Miller RF et al (2004) Imaging features of multicentric Castleman\u2019s disease in HIV infection. Clin Radiol 59(7):596\u2013601. https:\/\/doi.org\/10.1016\/j.crad.2003.10.025","journal-title":"Clin Radiol"},{"issue":"2","key":"7065_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00405-005-0963-9","volume":"263","author":"JJ Song","year":"2006","unstructured":"Song JJ, Jung MH, Woo JS, Chae SW, Hwang SJ, Lee HM (2006) Castleman\u2019s disease of the head and neck. Eur Arch Otorhinolaryngol 263(2):160\u2013163. https:\/\/doi.org\/10.1007\/s00405-005-0963-9","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"8","key":"7065_CR9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3109\/10428194.2011.574759","volume":"52","author":"DY Shin","year":"2011","unstructured":"Shin DY, Jeon YK, Hong YS et al (2011) Clinical dissection of multicentric Castleman disease. Leuk Lymphoma 52(8):1517\u20131522. https:\/\/doi.org\/10.3109\/10428194.2011.574759","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"7065_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/SLA.0b013e318249dcdc","volume":"255","author":"N Talat","year":"2012","unstructured":"Talat N, Belgaumkar AP, Schulte KM (2012) Surgery in Castleman\u2019s disease: a systematic review of 404 published cases. Ann Surg 255(4):677\u2013684. https:\/\/doi.org\/10.1097\/SLA.0b013e318249dcdc","journal-title":"Ann Surg"},{"issue":"915","key":"7065_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1259\/bjr\/52051980","volume":"77","author":"TY Tan","year":"2004","unstructured":"Tan TY, Pang KP, Goh HK, Teo EL, Abhilash B, Walford N (2004) Castleman\u2019s disease of the neck: a description of four cases on contrast-enhanced CT. Br J Radiol 77(915):253\u2013256. https:\/\/doi.org\/10.1259\/bjr\/52051980","journal-title":"Br J Radiol"},{"issue":"4","key":"7065_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s12032-009-9355-0","volume":"27","author":"B Ye","year":"2010","unstructured":"Ye B, Gao SG, Li W et al (2010) A retrospective study of unicentric and multicentric Castleman\u2019s disease: a report of 52 patients. Med Oncol 27(4):1171\u20131178. https:\/\/doi.org\/10.1007\/s12032-009-9355-0","journal-title":"Med Oncol"},{"issue":"23","key":"7065_CR13","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1182\/bloodadvances.2020003334","volume":"4","author":"F van Rhee","year":"2020","unstructured":"van Rhee F, Oksenhendler E, Srkalovic G et al (2020) International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv 4(23):6039\u20136050. https:\/\/doi.org\/10.1182\/bloodadvances.2020003334","journal-title":"Blood Adv"},{"issue":"1","key":"7065_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/tcmj.tcmj_15_20","volume":"33","author":"YJ Wu","year":"2021","unstructured":"Wu YJ, Su KY (2021) Updates on the diagnosis and management of multicentric Castleman disease. Tzu Chi Med J 33(1):22\u201328. https:\/\/doi.org\/10.4103\/tcmj.tcmj_15_20","journal-title":"Tzu Chi Med J"},{"issue":"9","key":"7065_CR15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.7150\/ijbs.4666","volume":"8","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Kishimoto T (2012) Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci 8(9):1227\u20131236. https:\/\/doi.org\/10.7150\/ijbs.4666","journal-title":"Int J Biol Sci"},{"issue":"2","key":"7065_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jth.12075","volume":"11","author":"A Falanga","year":"2013","unstructured":"Falanga A, Marchetti M, Vignoli A (2013) Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 11(2):223\u2013233. https:\/\/doi.org\/10.1111\/jth.12075","journal-title":"J Thromb Haemost"},{"issue":"10","key":"7065_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopha.2006.09.004","volume":"60","author":"M Kojima","year":"2006","unstructured":"Kojima M, Motoori T, Nakamura S (2006) Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients. Biomed Pharmacother 60(10):663\u2013672. https:\/\/doi.org\/10.1016\/j.biopha.2006.09.004","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"7065_CR18","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","volume":"123","author":"DC Fajgenbaum","year":"2014","unstructured":"Fajgenbaum DC, van Rhee F, Nabel CS (2014) HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood 123(19):2924\u20132933. https:\/\/doi.org\/10.1182\/blood-2013-12-545087","journal-title":"Blood"},{"issue":"10","key":"7065_CR19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.clml.2020.05.002","volume":"20","author":"TH Beckham","year":"2020","unstructured":"Beckham TH, Yang JC, Chau KW, Noy A, Yahalom J (2020) Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease. Clin Lymphoma Myeloma Leuk 20(10):685\u2013689. https:\/\/doi.org\/10.1016\/j.clml.2020.05.002","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"24","key":"7065_CR20","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1182\/blood-2014-07-586800","volume":"124","author":"TS Uldrick","year":"2014","unstructured":"Uldrick TS, Polizzotto MN, Aleman K et al (2014) Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood 124(24):3544\u20133552. https:\/\/doi.org\/10.1182\/blood-2014-07-586800","journal-title":"Blood"},{"issue":"20","key":"7065_CR21","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","volume":"132","author":"F van Rhee","year":"2018","unstructured":"van Rhee F, Voorhees P, Dispenzieri A et al (2018) International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood 132(20):2115\u20132124. https:\/\/doi.org\/10.1182\/blood-2018-07-862334","journal-title":"Blood"},{"issue":"16","key":"7065_CR22","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2018-11-884577","volume":"133","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhao AL, Duan MH et al (2019) Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease. Blood 133(16):1720\u20131728. https:\/\/doi.org\/10.1182\/blood-2018-11-884577","journal-title":"Blood"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-07065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-021-07065-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-07065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T04:08:34Z","timestamp":1649218114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-021-07065-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["7065"],"URL":"https:\/\/doi.org\/10.1007\/s00405-021-07065-0","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,4]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in this study involving human participants were following the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This was retrospective study, thus no informed consent was needed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}